Abstract
Background
This study was conducted to evaluate whether tissue transglutaminase (tTG) may be involved in airway inflammation of toluene diisocyanate-induced occupational asthma (TDI-OA).
Methods
We enrolled 93 patients with TDI-OA, 177 asymptomatic exposed subjects, 43 patients with allergic asthma, and 70 unexposed normal controls. The prevalence of serum immunoglobulin G (IgG) to tTG in the TDI-OA group (20.2%) was significantly higher than that in the three other groups (P < 0.001).
Results
TDI-OA patients with serum IgG to tTG had significantly lower methacholine PC20 values (P < 0.02) and significantly higher prevalence of specific immunoglobulin E to vapor type TDI–human serum albumin conjugate (P < 0.01; r 2 = 0.411, P < 0.05). TDI exposure could increase tTG activity via reactive oxygen species (ROS) production, which was found to cross-link with cytokeratin 19 on immunoblot analysis.
Conclusion
Therefore, TDI exposure may activate tTG via ROS-mediated mechanism in the airway epithelium leading to persistent airway inflammation in TDI-OA patients.
Similar content being viewed by others
References
Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol. 2002;2:213–24.
Chan-Yeung M, Malo JL, Tarlo SM, Bernstein L, Gautrin D, Mapp C, et al. Proceedings of the first Jack Pepys Occupational Asthma Symposium. Am J Respir Crit Care Med. 2003;167:450–71.
Boulet LP, Lemiere C, Gautrin D, Cartier A. New insights into occupational asthma. Curr Opin Allergy Clin Immunol. 2007;7:96–101.
Park HS, Cho SH, Hong CS, Kim YY. Isocyanate-induced occupational asthma in far-east Asia: pathogenesis to prognosis. Clin Exp Allergy. 2002;32:198–204.
Park HS, Nahm DH. Isocyanate-induced occupational asthma: challenge and immunologic studies. J Korean Med Sci. 1996;11:314–8.
Ye YM, Kim CW, Kim HR, Kim HM, Suh CH, Nahm DH, et al. Biophysical determinants of toluene diisocyanate antigenicity associated with exposure and asthma. J Allergy Clin Immunol. 2006;118:885–91.
Park HS, Hwang SC, Nahm DH, Yim HE. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma. J Korean Med Sci. 1998;13:21–6.
Park H, Jung K, Kim H, Nahm D, Kang K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy. 1999;29:1395–401.
Ye YM, Nahm DH, Kim CW, Kim HR, Hong CS, Park CS, et al. Cytokeratin autoantibodies: useful serologic markers for toluene diisocyanate-induced asthma. Yonsei Med J. 2006;47:773–81.
Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YM, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 2000;191:603–12.
Marsh MN. Transglutaminase, gluten and celiac disease: food for thought. Transglutaminase is identified as the autoantigen of celiac disease. Nat Med. 1997;3:725–6.
Marietta EV, Camilleri MJ, Castro LA, Krause PK, Pittelkow MR, Murray JA. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. J Invest Dermatol. 2008;128:332–5.
Alaedini A, Green PH. Autoantibodies in celiac disease. Autoimmunity. 2008;41:19–26.
Park HS, Kim HY, Nahm DH, Son JW, Kim YY. Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results. J Allergy Clin Immunol. 1999;104:847–51.
Yi SJ, Choi HJ, Yoo JO, Yuk JS, Jung HI, Lee SH, et al. Arachidonic acid activates tissue transglutaminase and stress fiber formation via intracellular reactive oxygen species. Biochem Biophys Res Commun. 2004;325:819–26.
Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM. Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA. 2003;100:2047–52.
Pezzini A, Riviera A, Paggiaro P, Spiazzi A, Gerosa F, Filieri M, et al. Specific IgE antibodies in twenty-eight workers with diisocyanate-induced bronchial asthma. Clin Allergy. 1984;14:453–61.
Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709–15.
Bernstein DI, Cartier A, Cote J, Malo JL, Boulet LP, Wanner M, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med. 2002;166:445–50.
Wisnewski AV, Redlich CA. Recent developments in diisocyanate asthma. Curr Opin Allergy Clin Immunol. 2001;1:169–75.
Lee YM, Kim HA, Park HS, Lee SK, Nahm DH. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: effect of pro-inflammatory cytokines. J Korean Med Sci. 2003;18:809–12.
Mapp CE, Fryer AA, De Marzo N, Pozzato V, Padoan M, Boschetto P, et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol. 2002;109:867–72.
Pauluhn J. Inhalation toxicity of 1, 6-hexamethylene diisocyanate homopolymer (HDI-IC) aerosol: results of single inhalation exposure studies. Toxicol Sci. 2000;58:173–81.
Lange RW, Day BW, Lemus R, Tyurin VA, Kagan VE, Karol MH. Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene. Chem Res Toxicol. 1999;12:931–6.
Wikman H, Piirila P, Rosenberg C, Luukkonen R, Kaaria K, Nordman H, et al. N-acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics. 2002;12:227–33.
Folkerts G, Kloek J, Muijsers RB, Nijkamp FP. Reactive nitrogen and oxygen species in airway inflammation. Eur J Pharmacol. 2001;429:251–62.
Cluzel M, Damon M, Chanez P, Bousquet J, Crastes de Paulet A, Michel FB, et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol. 1987;80:195–201.
Jarjour NN, Busse WW, Calhoun WJ. Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis. 1992;146:905–11.
Jarjour NN, Calhoun WJ. Enhanced production of oxygen radicals in asthma. J Lab Clin Med. 1994;123:131–6.
Kanazawa H, Kurihara N, Hirata K, Takeda T. The role of free radicals in airway obstruction in asthmatic patients. Chest. 1991;100:1319–22.
Kim SH, Park HJ, Lee CM, Choi IW, Moon DO, Roh HJ, et al. Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma. FEBS Lett. 2006;580:1883–90.
Lemiere C, Chaboillez S, Malo JL, Cartier A. Changes in sputum cell counts after exposure to occupational agents: what do they mean? J Allergy Clin Immunol. 2001;107:1063–8.
Chen JS, Mehta K. Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol. 1999;31:817–36.
Kim SY, Jeitner TM, Steinert PM. Transglutaminases in disease. Neurochem Int. 2002;40:85–103.
Sollid LM, Molberg O, McAdam S, Lundin KE. Autoantibodies in coeliac disease: tissue transglutaminase—guilt by association? Gut. 1997;41:851–2.
Choi JH, Nahm DH, Kim SH, Kim YS, Suh CH, Park HS, et al. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. Ann Allergy Asthma Immunol. 2004;93:293–8.
Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol. 1999;187:567–72.
Peterson LL, Zettergren JG, Wuepper KD. Biochemistry of transglutaminases and cross-linking in the skin. J Invest Dermatol. 1983;81:95s–100s.
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801.
Mowat AM. Coeliac disease—a meeting point for genetics, immunology, and protein chemistry. Lancet. 2003;361:1290–2.
Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2:647–55.
Zatloukal K, Denk H, Lackinger E, Rainer I. Hepatocellular cytokeratins as substrates of transglutaminases. Lab Invest. 1989;61:603–8.
Palosuo K, Varjonen E, Nurkkala J, Kalkkinen N, Harvima R, Reunala T, et al. Transglutaminase-mediated cross-linking of a peptic fraction of omega-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. J Allergy Clin Immunol. 2003;111:1386–92.
Acknowledgments
This study was supported by a grant from the Korean Health 12 R&D project, Ministry of Health & Welfare, Republic of Korea (A030001) and Daewoo Medical Foundation, 2008.
Author information
Authors and Affiliations
Corresponding author
Additional information
Gyu-Young Hur and Sung-Ho Kim equally contributed to this work.
Rights and permissions
About this article
Cite this article
Hur, GY., Kim, SH., Park, S.M. et al. Tissue Transglutaminase Can Be Involved in Airway Inflammation of Toluene Diisocyanate-Induced Occupational Asthma. J Clin Immunol 29, 786–794 (2009). https://doi.org/10.1007/s10875-009-9314-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-009-9314-8